Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Waiting too long to redeem credit card points can lead to lost rewards and missed opportunities. Learn how to maximize your benefits.
26,518 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
A federal jury in Chicago has awarded $49.5 million to the family of a 24-year-old nonprofit worker who died in the 2...
Rising rents and mortgage costs push households toward backyard ADUs. This report explains costs, timelines, and how ...
FXU climbs 17% over the past year as data centers reshape power demand, renewing growth for utilities and attracting ...
Two entertainment giants, Netflix and Disney, are navigating a fast-changing landscape. This analysis breaks down rec...
KLAC stock has captured investor attention as semiconductor tool demand shifts with AI and data growth. This guide br...
U.S. stocks moved higher as traders shrugged off renewed fighting in Iran, with gains led by technology and consumer ...
A new leave-planning method is turning a modest PTO bank into long, strategic breaks. The so-called 'pto-maxxing' sum...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
On May 29, markets extended their gains as Dell Technologies surged about 33% on better-than-expected earnings and AI...
Dell Technologies has moved from the shadows into the AI spotlight. This guide explains why the stock is drawing atte...
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...